The European, Middle Eastern and African Antitrust Review 2017

EU: Pharmaceuticals

20 July 2016

The EU National Competition Authorities (NCAs) have been very active in the pharmaceutical sector this year. While the European Commission (the Commission) has considered several concentrations, taking decisions that develop its analytical approach to the sector, the NCAs have led in the behavioural context.

Interested in becoming a GCR author? Please contact our Insight Manager.

Get in touch